Multi-Omic analyses characterize the ceramide/sphingomyelin pathway as a therapeutic target in Alzheimer's disease.
Baloni P, Arnold M, Buitrago L, Nho K, Moreno H, Huynh K, Brauner B, Louie G, Kueider-Paisley A, Suhre K, Saykin AJ, Ekroos K, Meikle PJ, Hood L, Price ND; Alzheimer’s Disease Metabolomics Consortium; Doraiswamy PM, Funk CC, Hernández AI, Kastenmüller G, Baillie R, Han X, Kaddurah-Daouk R.
Baloni P, et al.
Commun Biol. 2022 Oct 8;5(1):1074. doi: 10.1038/s42003-022-04011-6.
Commun Biol. 2022.
PMID: 36209301
Free PMC article.
Genome-wide and transcriptome-wide association studies have identified various genes and genetic variants in lipid metabolism that are associated with Alzheimer's disease. However, the molecular mechanisms of sphingomyelin and ceramide disruption remain to be determined. . …
Genome-wide and transcriptome-wide association studies have identified various genes and genetic variants in lipid metabolism that are assoc …